Advertisement

Ads Placeholder
Loading...

Innovative Eyewear, Inc.

LUCYNASDAQ
Healthcare
Medical - Instruments & Supplies
$1.08
$-0.02(-1.36%)
U.S. Market is Open • 10:38

Innovative Eyewear, Inc. Fundamental Analysis

Innovative Eyewear, Inc. (LUCY) shows moderate financial fundamentals with a PE ratio of -0.77, profit margin of -2.85%, and ROE of -0.33%. The company generates $0.0B in annual revenue with strong year-over-year growth of 41.99%.

Key Strengths

Cash Position112092.03%
PEG Ratio-0.04
Current Ratio9.03

Areas of Concern

ROE-0.33%
Operating Margin-3.19%
We analyze LUCY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -149.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-149.2/100

We analyze LUCY's fundamental strength across five key dimensions:

Efficiency Score

Weak

LUCY struggles to generate sufficient returns from assets.

ROA > 10%
-0.07%

Valuation Score

Excellent

LUCY trades at attractive valuation levels.

PE < 25
-0.77
PEG Ratio < 2
-0.04

Growth Score

Excellent

LUCY delivers strong and consistent growth momentum.

Revenue Growth > 5%
41.99%
EPS Growth > 10%
59.04%

Financial Health Score

Excellent

LUCY maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
9.03

Profitability Score

Weak

LUCY struggles to sustain strong margins.

ROE > 15%
-33.39%
Net Margin ≥ 15%
-2.85%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is LUCY Expensive or Cheap?

P/E Ratio

LUCY trades at -0.77 times earnings. This suggests potential undervaluation.

-0.77

PEG Ratio

When adjusting for growth, LUCY's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Innovative Eyewear, Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -779.37 times EBITDA. This is generally considered low.

-779.37

How Well Does LUCY Make Money?

Net Profit Margin

For every $100 in sales, Innovative Eyewear, Inc. keeps $-2.85 as profit after all expenses.

-2.85%

Operating Margin

Core operations generate -3.19 in profit for every $100 in revenue, before interest and taxes.

-3.19%

ROE

Management delivers $-0.33 in profit for every $100 of shareholder equity.

-0.33%

ROA

Innovative Eyewear, Inc. generates $-0.07 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.07%

Following the Money - Real Cash Generation

Operating Cash Flow

Innovative Eyewear, Inc. generates strong operating cash flow of $2.23B, reflecting robust business health.

$2.23B

Free Cash Flow

Innovative Eyewear, Inc. generates strong free cash flow of $2.23B, providing ample flexibility for dividends, buybacks, or growth.

$2.23B

FCF Per Share

Each share generates $559.64 in free cash annually.

$559.64

FCF Yield

LUCY converts 725.02% of its market value into free cash.

725.02%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.77

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.001

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.59

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

9.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How LUCY Stacks Against Its Sector Peers

MetricLUCY ValueSector AveragePerformance
P/E Ratio-0.7728.45 Better (Cheaper)
ROE-0.33%763.00% Weak
Net Margin-285.20%-45265.00% (disorted) Weak
Debt/Equity0.000.34 Strong (Low Leverage)
Current Ratio9.032795.60 Strong Liquidity
ROA-0.07%-16588.00% (disorted) Weak

LUCY outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Innovative Eyewear, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

2155.92%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-96.54%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ